Bristol-Myers Squibb Appoints Christopher Boerner Executive Vice President and Chief Commercial Officer


Aug 28, 2018-- Bristol-Myers Squibb Company today announced that Christopher Boerner, Ph.D., has been appointed executive vice president and chief commercial officer, effective immediately. Boerner succeeds Murdo Gordon, who departed the company on August 3, 2018, to pursue another opportunity.



from Biotech News